An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome

Shigeatsu Endo, Ryutaro Shimazaki, Satoshi Gando, Shigeto Oda, Yasuhiro Ootomo, Masanao Miura, Shinji Ogura, Yutaka Eguchi, Joji Kotani, Norio Yamashita, Hiroyasu Ishikura, Yuichiro Sakamoto, Takeshi Takahashi, Yasushi Suzuki, Shigeki Kushimoto, Nobuya Kitamura, Naoyuki Matsuda, Takahiro Fujita, Mitsuhide Kitano, Junko YamaguchiYoshikazu Yasuda, Hayato Takayama, Toshiharu Tanaka, Tetsuya Matsuoka, Tetsuhiro Takei, Tsuyoshi Hatada, Masahiro Tamashiro, Satoshi Fujimi, Osamu Nishida, Kazuhito Tamehiro, Junichi Maehara, Shinsuke Fujiwara, Hideo Wada

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences